In addition, 89% sensitivity and 100% specificity for the diagnosis of high-grade IPMN and invasive IPMN were obtained by combining KRAS/GNAS mutation and TP53/PIK3CA/PTEN alterations [54]. This evidence concerns the gene TP53 and pancreatic intraductal papillary-mucinous neoplasm.